Articles tagged with Vaccine Research
Australian scientists have discovered how T follicular helper cells tailor their behavior to different infections, paving the way for improved vaccine design and targeted therapies. The study sheds light on a molecular 'instruction manual' guiding antibody production and long-term immunity.
The University of California - Riverside is receiving a $2 million grant to investigate how gut microbes interact with their human hosts to influence health. The research aims to create next-generation probiotics that strengthen the gut microbiome, improve vaccine effectiveness, and prevent infections.
Scientists found that stretching the skin stimulates immune cells and increases its ability to absorb large molecules, including vaccines. This approach resulted in higher antibody levels against the H1N1 flu antigen compared to traditional needle-free delivery methods.
A chemically modified STn glycoconjugate vaccine has been developed with enhanced antitumor immunity, demonstrating substantial resistance to enzymatic degradation and inducing potent T-cell responses. The vaccine induces functional antibodies capable of initiating both CDC and ADCC against STn-positive tumor cells.
Research with human fetal tissue has been instrumental in advancing biomedicine and saving millions of lives. The ISSCR asserts that this work is essential for understanding human development, infertility, and diseases like diabetes and neurodegenerative disorders.
A new project aims to increase HPV vaccine uptake by harnessing AI to tailor health information to parents' specific concerns and communication styles. The AI-driven chatbot will simulate human conversation, addressing misconceptions and fears associated with the vaccine.
A comprehensive registry study in Sweden found that healthy, full-term babies under three months old are at risk of severe illness from RSV. The study highlights several risk factors, including birth weight and sibling age, which increase the risk of needing intensive care or dying.
Stefan Kappe, a leading expert in genetic engineering of parasites, has been appointed as the new Director of the Center for Vaccine Development and Global Health at UM School of Medicine. He will focus on developing genetically engineered live-attenuated pathogens to combat malaria infection.
Researchers developed a high-volume method to rapidly build and test large numbers of antibodies at once, accelerating antibody research and treatment development. The oPool+ display platform has potential applications in influenza vaccination research, infectious disease treatment, and cancer research.
Researchers at Texas Biomed have developed a live attenuated vaccine that showed high efficacy in cells and animal models, protecting mice from lethal H5N1. The team identified potential treatment targets using human airway organoids, revealing how bird flu remodels airway cells and causes scar tissue to form.
A new vaccine developed to protect against 21 strains of pneumococcus will be tested in a randomised controlled trial, aiming to provide greater protection for babies against serious infections. The trial is recruiting over 1600 babies across Australia and internationally.
Researchers found that HPV16 undermines the body's defenses by reprogramming immune cells surrounding tumors. Blocking IL-23 boosts experimental treatments for HPV to eliminate cancer cells.
A new study finds reported conflicts of interest on CDC vaccine panels had been at historic lows for years before Kennedy's dismissal. The type of conflict typically considered most concerning, income from vaccine makers, was virtually eliminated among panel members.
Researchers discovered that vaccines induce changes in stromal cells of draining lymph nodes within hours, priming the landscape for immune responses. Different vaccines activate lymph node stromal cells differently, with some inducing specific effects on lymphatic endothelial cells.
MIT researchers have developed a method to reveal the inner workings of protein language models, which can accurately predict proteins suitable for drug or vaccine targets. By analyzing sparse representations of proteins, they identified key features that drive these predictions.
Researchers used machine-learning models to design nanoparticles that can deliver RNA to cells more efficiently. The approach accelerated the identification of optimal ingredient mixtures in lipid nanoparticles, leading to better delivery vehicles for RNA vaccines and mRNA therapies. This could dramatically speed up the development of ...
A comprehensive epidemiological study found that people who had COVID-19 are at increased risk of developing certain inflammatory diseases of the airways, such as asthma and chronic sinusitis. Vaccination against SARS-CoV-2 virus appears to reduce this risk.
A recent study reveals woefully low awareness of human papillomavirus (HPV), the HPV vaccine, and their association with cancer in the Midwestern and Southern US states. These states have seen a rise in HPV-associated cancers, making suboptimal HPV vaccination rates even more alarming.
New research reveals that most people are unaware of the link between human papillomavirus (HPV) and various types of cancer, including cervical, oropharyngeal, anal, vaginal, vulvar, and penile cancers. The study highlights the importance of HPV vaccination in preventing these cancers.
This book delves into the scientific foundations of mucosal vaccine platforms, discussing immunological mechanisms, novel adjuvants, and real-world development challenges. It serves as a valuable resource for professionals and students in life sciences, immunology, and pharmacology.
A novel cancer vaccine has shown encouraging early results in patients with pancreatic and colorectal cancer, two of the most difficult-to-treat malignancies. The vaccine targets KRAS mutations found in about 25% of solid tumors and drives about 90% of pancreatic cancers and 50% of colorectal cancers.
Key findings show a decline in childhood and adolescent immunization rates in Michigan, with completion rates dropping sharply during the COVID-19 pandemic. The study highlights the need for targeted efforts to increase immunization rates in counties with lower income and higher uninsurance rates.
A multi-year clinical research study in US children documents the rebound of endemic respiratory viruses after the COVID-19 pandemic. The study shows that non-pharmaceutical interventions decreased circulation rates of common respiratory pathogens in children, enabling more accurate predictions for future outbreaks.
Researchers at CUNY ASRC discover that simple tripeptides can encapsulate proteins and protect them from stress, opening up possibilities for protein preservation without refrigeration. This breakthrough could lead to innovative vaccine distribution methods and smart materials.
The study found that the vaccine effectively induces a rapid mucosal and systemic IgA response, but its protective effect against emerging variants like JN.1 appears short-lived. The results highlight the need for improved mucosal vaccine platforms capable of inducing durable immunity.
Researchers have demonstrated a novel vaccine delivery method using dental floss, which stimulates the production of antibodies in mucosal surfaces, such as the lining of the nose and lungs. This technique has shown superior antibody response compared to current oral vaccination methods.
Researchers at Nagoya University have developed a new lipid nanoparticle that delivers mRNA five times more efficiently, allowing better delivery of genetic instructions to cells. The study showed significant improvements in mRNA delivery and effective suppression of tumor growth in mice.
Researchers developed an IBDV VP2 subunit vaccine that induces specific antibodies and protects against bursal atrophy. The study found that using certain adjuvants, such as Montanide ISA 78 VG, enhances the protective effects of the vaccine.
A genetic study in mice reveals that TB bacteria can survive in vaccinated or previously infected hosts by switching strategies and relying on different genes. The research could lead to the creation of treatments given alongside vaccines to help the immune system root out TB when it tries to hide.
A novel formulation and delivery approach for the NeoVax personalized cancer vaccine improved immune responses in patients with melanoma. The updated vaccine demonstrated strong vaccine-specific immune responses and cytotoxic responses by special T cells called CD-8+ T cells.
Djenet Bousbaine's research explores how the immune system responds to beneficial skin microbes, triggering wound-healing T cells and robust B cell responses. This phenomenon is observed in humans, non-human primates, and found to be evolutionary conserved.
Renowned vaccine expert Pierre Van Damme shared his experience leading over 500 clinical trials and establishing Vaccinopolis, a global research hub for vaccine clinical trials. The Vaccine Innovation Center of Korea University's College of Medicine aims to expand global cooperation in vaccine R&D through special seminars.
Researchers at MIT and Scripps Research Institute developed a vaccine that generates many more HIV-targeting B cells in mice with just one dose, using two adjuvants. The dual-adjuvant vaccine produces a wider diversity of antibodies against an HIV antigen, allowing the immune system to build up a stronger response.
Scientists have modified mRNA vaccines to include the cytokine IL-12, enhancing T cell responses and improving protection against diseases such as SARS-CoV-2, influenza, melanoma, and listeria infection. The study's findings suggest a promising approach to enhance immune stimulation against cancer and other pathogens.
Researchers at Cornell University have developed a new lipid nanoparticle that replaces PEG with poly(carboxybetaine) to improve mRNA vaccine delivery. This stealthy material helps vaccines evade the immune system while inducing targeted immune responses, making it more effective for cancer vaccines.
Researchers from the University of Cincinnati have engineered bacteria to deliver antiviral therapies and vaccines orally, bypassing traditional methods. The engineered bacteria use outer-membrane vesicles as self-propelled delivery vehicles, targeting mucosal surfaces to provide mucosal immunity.
A new study by University of Illinois researchers highlights the need for flexible approaches to reach diverse audiences with disease prevention strategies. The findings underscore that there is no one-size-fits-all solution to public health challenges, and understanding people's value systems can help inform policy recommendations.
Researchers have developed a cheap and sustainable way to produce ionisable lipids from cashew nutshell liquid, a by-product of the cashew industry. This breakthrough could transform the future of vaccine production and support Africa's target of producing 60% of its vaccines locally by 2040.
Researchers from Amsterdam UMC have made a breakthrough in developing an HIV vaccine with a germline-targeting strategy, inducing immune responses in participants. The phase one trial showed promising results, suggesting the potential for this approach to be further developed into a vaccine.
A new AI model, EVE-Vax, uses evolutionary data to predict viral proteins and design future-proof vaccines against rapidly mutating viruses like SARS-CoV-2. By analyzing millions of years of genetic information, the model can create brand-new proteins with the same immune response as real viruses.
Researchers from Japan evaluate the LC16m8 vaccine, an attenuated vaccinia virus strain, for its efficacy and safety against mpox. The study confirms the vaccine's ability to induce strong immune responses and protect against mpox in mice, monkeys, and humans.
Researchers discovered 500 cryptic peptides found only in pancreatic tumors, which could be targeted by vaccines or engineered T cells to attack the cancer. The peptides were identified using immunopeptidomics and shown to slow down tumor growth in mice.
Scientists have discovered a novel way to enhance the effectiveness of vaccines by boosting stem cell-like memory CD8+ T cells, which can provide decades-long immunity. The study uses mRNA vaccine technology to increase the formation of these cells, offering a promising solution for viruses and cancer therapies.
A novel vaccine platform uses genetically fused antigen to albumin, which is actively transported across the mucosal barrier by FcRn receptor. This results in protective systemic and mucosal antibody responses against SARS-CoV-2 and influenza A.
A new study from Murdoch University confirms that COVID-19 vaccinations do not cause significant metabolic changes. The research monitored 167 metabolic markers in 33 participants over 480 days post-vaccination, showing no significant impact on key health indicators.
Scientists discovered that receiving a booster vaccine in the same arm as the first dose generates a more effective immune response quickly. Memory B cells interact with 'primed' macrophages in lymph nodes to produce high-quality antibodies.
The CoVaRR-Net network successfully bridged critical research and public health gaps exposed by the COVID-19 pandemic through interdisciplinary collaboration and innovative approaches like wastewater surveillance. Its achievements include 139 peer-reviewed publications, evidence-based public health decisions, and a global leader in ear...
A recent study by Stanford Medicine researchers warns that measles and other diseases may make a comeback in the US if immunization rates drop. The study found that even at current levels, measles may become endemic within two decades, leading to an estimated 851,300 cases over 25 years.
A landmark study found that a single oral dose of baloxavir marboxil significantly reduces influenza transmission within households. Conducted across 15 countries, the CENTERSTONE trial provides robust evidence for an antiviral treatment's potential to curb the spread of influenza.
Researchers found a significant difference in parental support for adolescent consent when the question was framed using "Mature Minor Doctrine" versus describing specific scenarios. The study suggests that clear and detailed information can greatly impact parents' opinions on these issues.
The study found that influenza vaccination rates increased for Black and Hispanic older adults in rural areas, while decreasing for some white older adults. Determining the reasons behind these disparities is crucial for future research.
Researchers found a novel virus in the model green alga Chlamydomonas reinhardtii, which is the largest temperate virus discovered to date with a latent infection cycle. The discovery sheds light on potential biotechnological applications, including gene editing.
Researchers found that full-genome differences between rotavirus strains influence vaccine effectiveness, highlighting the need for a broader approach to vaccine design. The study's results suggest that vaccines should be designed based on the whole genome of circulating strains, rather than just two surface proteins.
Researchers have developed an effective approach to tackle intestinal pathogens by administering oral vaccinations combined with harmless bacteria that starve out pathogenic microbes. This method has shown promising results in preventing colonization with salmonella and effectively tackling established E. coli bacteria.
A new study by researchers at McGill University found that annual COVID-19 vaccine booster doses help avoid breakthrough infections in people with immune-mediated inflammatory diseases. The study tracked 366 patients across Canada and used saliva PCR tests and antibody measurements, offering a more precise picture of infection risks.
A new study reveals Japanese citizens broadly susceptible to illiberal narratives, posing risks to Japan's political discourse. The research found that illiberal narratives exert a stronger influence than mainstream democratic messaging.
Researchers develop AI model to predict novel mutations in protein sequences, combining grammatical and semantic changes. The method uses all available information about the sequence and mutations to create a more accurate prediction model.
Researchers at Lancaster University discovered a new type of vaccine-specific scepticism, where some people perceive COVID-19 vaccines as 'not a vaccine' compared to MMR. This phenomenon may also apply to the flu vaccine, highlighting the need for clear public health messaging.
Scientists at Sanford Burnham Prebys developed a new method of generating antibodies by fusing two immune system proteins, enabling the creation of stable monoclonal antibodies. This breakthrough has potential applications in diagnosing and monitoring diseases such as lupus and cancers.
Thomas Jefferson University has initiated a phase 1 clinical trial for a Lassa virus (LASV) vaccine, currently enrolling healthy volunteers. The vaccine's safety and immunogenicity will be assessed in both the rabies virus and LASV.